Lidocaine Hydrochloride Injection, Solution
Product Images NDC 51662-1454

6 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 51662-1454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (51662 1454 1 Table 1)

Table 1 (51662 1454 1 Table 1)
A data table showing concentration, volume, and pH for Lidocaine Hydrochloride injection solution. It lists 5 mL volumes containing either 100 mg or 50 mg total Lidocaine HCl, at concentrations of 20 mg/mL and 10 mg/mL respectively, with pH ranges of 5.0 to 7.0 for intravenous direct injection and single-dose use.*
FDA Label Image

Structure (51662 1454 1 Structure)

Structure (51662 1454 1 Structure)
Chemical structure of lidocaine hydrochloride showing the aromatic ring with two methyl groups and the side chain containing an amide and diethylamino groups, along with hydrochloride and hydrate components.*
FDA Label Image

Rfid Label (51662 1454 1 Rfid)

Rfid Label (51662 1454 1 Rfid)
A white rectangular label for Lidocaine Hydrochloride Injection, Solution 20 mg/mL distributed by HF Acquisition Co LLC, DBA HealthFirst in Mukilteo, WA 98275. The label includes a machine-readable Data Matrix barcode, serialized and batch identification numbers, and a reminder to see the manufacturer's insert. The label indicates the product is RX only.*
FDA Label Image

Case Label (51662 1454 1 Carton Label)

Case Label (51662 1454 1 Carton Label)
Packaging label for Lidocaine HCl Injection USP, 2% strength (100 mg/5 mL, equivalent to 20 mg/mL), in a 5 mL single-dose syringe. The label includes usage instructions, manufacturer Hospira Inc., and highlights that the product is preservative free and intended for intravenous use for ventricular arrhythmias.*
FDA Label Image

Label (51662 1454 2 Pouch)

Label (51662 1454 2 Pouch)
Label for Lidocaine Hydrochloride injection, USP, 2% (20 mg/mL) in a 5 mL single-dose syringe. The product NDC is 51662-1454-2. The label provides lot number 789210 and expiration date 2030-09-19. Distributed by HF Acquisition Co LLC, Mukilteo, WA 98275, the label includes preparation and storage instructions, and a QR code.*
FDA Label Image

Label (51662 1454 3 Case)

Label (51662 1454 3 Case)
Label for 2% Lidocaine Hydrochloride Injection, USP, 100 mg/5 mL (20 mg/mL) in a 5 mL syringe, sold as a case of 10. The label includes NDC 51662-1454-3, lot number 789210, and expiration date 2030-09-19. Distributed by HF Acquisition Co., LLC, Mukilteo, WA. Additional text describes storage, usage, and formulation details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.